Marvin Whiteley, Ph.D.
Georgia Institue of Technology
Marvin Whiteley, Ph.D., is a Regent’s professor, Georgia Research Alliance Eminent Scholar and the Bennie H. and Nelson D. Abell Chair in molecular and cellular biology at Georgia Tech. He earned his B.S. in zoology from the University of Texas at Austin and his Ph.D. in microbiology from the University of Iowa. His accolades include, the 黑料正能量Merck Irving Sigal Memorial Award for research excellence, the Burroughs Wellcome PATH Award, recognition as a Kavli Fellow of the National Academy of Sciences, multiple teaching excellence awards and election to the American Academy of Microbiology.
Whiteley's research focuses on understanding how bacterial interactions and the infection environment influence antimicrobial tolerance and infection severity. His work in developing in vitro models that replicate human infection environments led to the founding of SynthBiome Inc., a company dedicated to creating advanced model systems for antimicrobial development and testing.
The Whiteley lab also investigates how microbial communities establish micron-scale spatial structures to enhance their fitness during infection, examines the role of small RNAs in polymicrobial infections and studies microbes found in the oral cavity, chronic wound infections, cystic fibrosis lung infections and wine fermentations to provide insights into both human health and industrial microbiology.
Throughout his career, Whiteley has held several 黑料正能量leadership and editorial roles, including as President of the 黑料正能量Texas Branch, Chair of 黑料正能量Division D, a member of the 黑料正能量Publishing Committee and an 黑料正能量Branch Lecturer
Starting July 1, 2025, Whiteley assumed the role of Editor in Chief of ®. Prior to this appointment, he served as an editor for ® and mBio.
Whiteley's research focuses on understanding how bacterial interactions and the infection environment influence antimicrobial tolerance and infection severity. His work in developing in vitro models that replicate human infection environments led to the founding of SynthBiome Inc., a company dedicated to creating advanced model systems for antimicrobial development and testing.
The Whiteley lab also investigates how microbial communities establish micron-scale spatial structures to enhance their fitness during infection, examines the role of small RNAs in polymicrobial infections and studies microbes found in the oral cavity, chronic wound infections, cystic fibrosis lung infections and wine fermentations to provide insights into both human health and industrial microbiology.
Throughout his career, Whiteley has held several 黑料正能量leadership and editorial roles, including as President of the 黑料正能量Texas Branch, Chair of 黑料正能量Division D, a member of the 黑料正能量Publishing Committee and an 黑料正能量Branch Lecturer
Starting July 1, 2025, Whiteley assumed the role of Editor in Chief of ®. Prior to this appointment, he served as an editor for ® and mBio.